Related Experiment Video
Updated: Aug 25, 2025
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Optical Coherence Tomography Biomarkers for Conversion to Exudative Neovascular Age-related Macular Degeneration
Yu Wakatsuki1, Kazutaka Hirabayashi1, Hannah J Yu2
1From the Doheny Eye Institute, Los Angeles, California (Y.W., K.H., K.M.M., G.C., S.R.S.); Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA (Y.W., K.H., G.C., S.R.S.).
Purpose:
To identify optical coherence tomography (OCT) biomarkers, including thin and thick double-layer sign (DLS) for the progression from intermediate AMD (iAMD) to exudative macular neovascularization (MNV) over 24 months.
Design:
Retrospective cohort study.
Methods:
Setting: Retina consultants of Texas.
Patient Population:
458 eyes of 458 subjects with iAMD in at least 1 eye with 24 months of follow-up data.
Main Outcomes Measures:
The following biomarkers were assessed at baseline: high central drusen volume (≥0.03 mm3), intraretinal hyper-reflective foci (IHRF), subretinal drusenoid deposits, hyporeflective drusen cores, thick DLS, thin DLS, and central choroidal thickness. A binary logistic regression was computed to investigate the association between baseline OCT covariates and the conversion to exudative MNV within 24 months. In addition, fellow eye status was also included in the model.
Results:
During follow-up, 18.1% (83 of 458) of eyes with iAMD progressed to exudative MNV. Thick DLS, IHRF, and fellow eye exudative MNV were found to be independent predictors for the development of exudative MNV within 2 years. The baseline frequencies, odds ratios, 95% confidence intervals, and P values for these biomarkers were as follows: thick DLS (9.6%, 4.339, 2.178-8.644; P < .001), IHRF (36.0%, 2.340, 1.396-3.922; P = 0.001), and fellow eye exudative MNV (35.8%, 1.694, 1.012-2.837; P = .045).
Conclusions:
Thick DLS, IHRF, and fellow eye exudative MNV were associated with an increased risk of progression from iAMD to exudative MNV. These biomarkers, which are readily identified by the review of OCT volume scans, may aid in risk prognostication for patients and for identifying patients for early intervention trials.
